Ralph Quimbo

720 total citations
30 papers, 564 citations indexed

About

Ralph Quimbo is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Surgery. According to data from OpenAlex, Ralph Quimbo has authored 30 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Economics and Econometrics and 10 papers in Surgery. Recurrent topics in Ralph Quimbo's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Diabetes Management and Research (8 papers) and Diabetes Treatment and Management (7 papers). Ralph Quimbo is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Diabetes Management and Research (8 papers) and Diabetes Treatment and Management (7 papers). Ralph Quimbo collaborates with scholars based in United States, United Kingdom and Netherlands. Ralph Quimbo's co-authors include Mark J. Cziraky, Michael Grabner, John J. Barron, Peter P. Tóth, Mayur M. Amonkar, Judith J. Stephenson, Swetha Palli, Lin Chang, Kristijan H. Kahler and Jeffrey Kralstein and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Cardiology and Atherosclerosis.

In The Last Decade

Ralph Quimbo

30 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ralph Quimbo United States	12	200	156	92	71	58	30	564
Josephina G. Kuiper Netherlands	13	154 0.8×	87 0.6×	54 0.6×	182 2.6×	65 1.1×	37	640
Uyen Duong United States	18	376 1.9×	203 1.3×	61 0.7×	95 1.3×	51 0.9×	18	1.1k
Paul J. Dluzniewski United States	11	90 0.5×	155 1.0×	64 0.7×	68 1.0×	35 0.6×	22	478
Nicholas Sicignano United States	14	203 1.0×	205 1.3×	27 0.3×	27 0.4×	43 0.7×	37	727
Shaum Kabadi United States	16	102 0.5×	91 0.6×	27 0.3×	86 1.2×	197 3.4×	36	663
Simona de Portu Switzerland	18	595 3.0×	394 2.5×	41 0.4×	27 0.4×	33 0.6×	61	928
Abdulaali R. Almutairi Saudi Arabia	11	132 0.7×	89 0.6×	45 0.5×	189 2.7×	67 1.2×	48	597
Adrian Kielhorn United States	15	38 0.2×	39 0.3×	87 0.9×	54 0.8×	35 0.6×	55	601
Arielle G. Bensimon United States	12	21 0.1×	105 0.7×	123 1.3×	73 1.0×	150 2.6×	34	543
Dirk J. van Veldhuisen Netherlands	6	61 0.3×	213 1.4×	12 0.1×	101 1.4×	16 0.3×	10	685

Countries citing papers authored by Ralph Quimbo

Since Specialization

Citations

This map shows the geographic impact of Ralph Quimbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Quimbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Quimbo more than expected).

Fields of papers citing papers by Ralph Quimbo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Quimbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Quimbo. The network helps show where Ralph Quimbo may publish in the future.

Co-authorship network of co-authors of Ralph Quimbo

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Quimbo. A scholar is included among the top collaborators of Ralph Quimbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Quimbo. Ralph Quimbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kern, David M., Lawrence Chang, Kalyani Sonawane, et al.. (2018). Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population. Rheumatology and Therapy. 5(2). 355–369. 24 indexed citations

Power, Thomas P., Xuehua Ke, Zhenxiang Zhao, et al.. (2018). Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease. Vascular Health and Risk Management. Volume 14. 23–36. 6 indexed citations

Kern, David M., John J. Barron, Bingcao Wu, et al.. (2017). A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data. PubMed. Volume 8. 149–155. 13 indexed citations

Grabner, Michael, Deborah A. Winegar, Rajeshwari Punekar, et al.. (2016). Cost Effectiveness of Achieving Targets of Low-Density Lipoprotein Particle Number Versus Low-Density Lipoprotein Cholesterol Level. The American Journal of Cardiology. 119(3). 404–409. 6 indexed citations

Barron, John, Jennifer L. Malin, Alex Ganetsky, et al.. (2016). Validity of clinical information for a novel cancer care quality program.. Journal of Clinical Oncology. 34(15_suppl). e18003–e18003. 2 indexed citations

Grabner, Michael, Swetha Palli, Ralph Quimbo, & Hope S. Rugo. (2015). The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting. Cancer Management and Research. 7. 175–175. 11 indexed citations

Malin, Jennifer L., et al.. (2015). Impact of enhanced reimbursement on provider participation a cancer care quality program and adherence to cancer treatment pathways in a commercial health plan.. Journal of Clinical Oncology. 33(15_suppl). 6571–6571. 3 indexed citations

Tóth, Peter P., Michael Grabner, Rajeshwari Punekar, et al.. (2014). Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets. Atherosclerosis. 235(2). 585–591. 48 indexed citations

Grabner, Michael, et al.. (2013). Clinical and Economic Outcomes Among Patients With Diabetes Mellitus Initiating Insulin Glargine Pen Versus Vial. Postgraduate Medicine. 125(3). 204–213. 31 indexed citations

10.

Wei, Wenhui, Erin Buysman, Lee Brekke, et al.. (2013). The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy. Advances in Therapy. 30(12). 1128–1140. 21 indexed citations

11.

Grabner, Michael, et al.. (2013). Estimated Cost Savings Associated With A1c Reductions In A Large Us Commercial Health Plan. Value in Health. 16(3). A160–A160. 4 indexed citations

12.

Quimbo, Ralph, Swetha Palli, Joseph Singer, & Marcie Strauss. (2012). PIN13 The Incremental Economic Burden of Clostridium-Difficile Associated Diarrhea Among Hospitalized Patients at High Risk of Recurrent Infection. Value in Health. 15(4). A239–A239. 2 indexed citations

13.

Tóth, Peter P., et al.. (2012). The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus. Cardiovascular Diabetology. 11(1). 109–109. 72 indexed citations

14.

Grabner, Michael, Wenhui Wei, Ralph Quimbo, et al.. (2012). PDB6 Real-World Comparative Effectiveness Analysis of Patients Initiating Injectable Treatments for Type 2 Diabetes Mellitus (T2DM): Pilot Data From the Initiator Study. Value in Health. 15(7). A494–A494. 1 indexed citations

15.

Pawaskar, Manjiri, et al.. (2011). Hypoglycemia in patients with type 2 diabetes using concomitant exenatide BID and long-acting insulin therapy. Journal of Medical Economics. 14(6). 705–708. 6 indexed citations

16.

Fabunmi, Rosalind P., Loretta L. Nielsen, Ralph Quimbo, et al.. (2009). Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine. Current Medical Research and Opinion. 25(3). 777–786. 62 indexed citations

17.

Charland, Scott L., Mark J. Cziraky, Ralph Quimbo, et al.. (2008). Achieving optimal lipid values in patients with dyslipidemia is associated with reduced risk of cardiovascular events. Journal of clinical lipidology. 2(5). 343–353. 6 indexed citations

18.

Quimbo, Ralph, et al.. (2008). Attainment of combined optimal lipid values and the impact of lipid medication on cardiovascular outcomes and costs in a commercially insured population in the US. Journal of Medical Economics. 11(3). 449–470. 3 indexed citations

19.

Chang, Lin, Kristijan H. Kahler, Chaitanya Sarawate, Ralph Quimbo, & Jeffrey Kralstein. (2007). Assessment of potential risk factors associated with ischaemic colitis. Neurogastroenterology & Motility. 20(1). 36–42. 53 indexed citations

20.

Barron, John J., et al.. (2007). Assessing the economic burden of breast cancer in a US managed care population. Breast Cancer Research and Treatment. 109(2). 367–377. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact